Verastem Oncology
VSTM
#7853
Rank
S$0.35 B
Marketcap
$7.99
Share price
-2.29%
Change (1 day)
-49.40%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2024 (TTM): -S$0.13 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are S$10 Million. In 2023 the company made an earning of -S$0.12 Billion a decrease over its 2022 earnings that were of -S$98.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.13 Billion5.77%
2023 -S$0.12 Billion18.36%
2022 -S$98.83 Million3.67%
2021 -S$95.33 Million5.43%
2020 -S$90.42 Million-54.74%
2019 -S$0.2 Billion105.99%
2018 -S$96.99 Million6.83%
2017 -S$90.79 Million86.06%
2016 -S$48.79 Million-37.03%
2015 -S$77.48 Million8.43%
2014 -S$71.46 Million29.52%
2013 -S$55.17 Million28.6%
2012 -S$42.9 Million133.9%
2011 -S$18.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$60 Million-52.05%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.29 B-7,529.32%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.10 B-979.90%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.58 B-4,563.02%๐Ÿ‡ฌ๐Ÿ‡ง UK